Virological response in patients infected with genotype 2 (A) or genotype 3 (B), and according to viral load (> or ≤ 800 000 IU/mL). Although not statistically significant, patient therapeutic education was beneficial in all patient subgroups, especially in those with genotype 2 and low viral load, with a marked impact on the SVR (SVR, P = 0.038) and relapse (P = 0.047) rates.